LeevyC. M.TamburroC. H.ZettermanR.: Liver Diseases of the Alcoholic, Med. Clin. TV. Am.59: 909–918 (July) 1975.
2.
WitteM. H.WitteC. L.DumontA. E.: Progress in Liver Disease: Physiological Factors Involved in the Causation of Cirrhotic Ascites, Gastroenterology61: 742–750 (Nov.) 1971.
3.
LieberC. S.: Liver Adaptation and Injury in Alcoholism, TV. Engl. J. Med.288: 356–362 (Feb.) 1973.
4.
OrloffM. J.: Pathogenesis and Surgical Treatment in Intractable Ascites Associated with Alcoholic Cirrhosis, Ann. TV. Y. Acad. Sci.170: 213–238 (July) 1970.
5.
FaloonW. W.: Pathophysiology, 1st ed., FrolichE. D., Editor. J. B. Lippincott Co., Philadelphia, Pa. pp. 461–462, 1972.
ZimonD. S.OratzM.KeelerR.: Albumin to Ascites: Demonstration of a Direct Pathway Bypassing the Systemic Circulation, J. Clin. Invest.48: 2074–2078 (Nov.) 1969.
8.
SchroederE. T.EichR. H.SmulyanH.: Plasma Renin Level in Hepatic Cirrhosis, Am. J. Med.49: 186–191 (Aug.) 1970.
9.
HenleyK. S.StreetenD. H. P.PollardH. M.: The Treatment of Refractory Ascites by Adrenalectomy and by the Administration of Spirolactones, Gastroenterology38: 681–689 (May) 1960.
10.
WolffH. P.BetteL.BlaiseH.: Role of Aldosterone in Edema Formation, Ann. N. Y. Acad. Sci.139: 285–294 (Nov.) 1967.
11.
SadeeW.DagciogluM.SchroderR.: Pharmacokinetics of Spironolactone, Canrenone and Canrenoate-K in Humans, J. Pharmacol. Exp. Ther.185: 686–695 (June) 1973.
12.
LiddleG. W.: Aldosterone Antagonists and Triamterene, Ann. N. Y. Acad. Sci.139: 466–470 (Nov.) 1967.
13.
RosoffL.PriscillaZ.ReynoldsT.: Studies of Renin and Aldosterone in Cirrhotic Patients with Ascites, Gastroenterology69: 698–705 (Sept.) 1975.
14.
LiebermanF. L.DenisonE. K.ReynoldsT. B.: The Relationship of Plasma Volume, Portal Hypertension, Ascites and Renal Sodium Retention in Cirrhosis: The Overflow Theory of Ascites Formation, Ann. N. Y. Acad. Sci.170: 202–212 (July) 1970.
15.
KimbleM. A.: Applied Therapeutics for Clinical Pharmacists, 1st ed., Applied Therapeutics Inc., San Francisco, Ca. pp. 48, 1975.
16.
GabuzdaG. J.: Cirrhotic Ascites: An Etiologic Approach to Management, Hosp. Prac.8: 67–74 (Aug.) 1973.
17.
ChaimovitzC.SzylmanP.AlroyG.: Mechanism of Increased Renal Tubular Sodium Reabsorption in Cirrhosis, Am. J. Med.52: 198–202 (Feb.) 1972.
18.
ConnH. O.: Progress in Liver Disease, Volume 4. PopperH.SchaffnerF. (Eds.). Grune and Stratton, New York, N. Y. pp. 269–285, 1972.
19.
LosowskyM. S.JonesD. P.LieberC. S.: Local Factors in Ascitic Formation During Sodium Retention in Cirrhosis, N. Engl. J. Med.268: 651–653 (Mar.) 1963.
20.
LosowskyM. S.DavidsonC. S.: The Treatment of Cirrhosis of the Liver, N. Engl. J. Med.267: 87–90 (July) 1962.
21.
GabuzdaG. J.: Cirrhosis, Ascites and Edema — Clinical Course Related to Management, Gastroenterology58: 546–553 (Apr.) 1970.
22.
EggertR. C.: Spironolactone Diuresis in Patients with Cirrhosis and Ascites, Br. Med. J.4: 401–403 (Nov.) 1970.
23.
VesinP.: Potassium Metabolism and Diuretics Administration in Liver Cirrhosis, Postgrad. Med. J.51: 545–548 (Aug.) 1975.
SherlockS.WalkerJ. G.InewiratoneB.: The Complication of Diuretic Therapy in Patients with Cirrhosis, Ann. N. Y. Acad. Sci.139: 497–505 (Nov.) 1967.
31.
ShearL.KleinermanJ.GabuzdaG. J.: Renal Failure in Patients with Cirrhosis, Am. J. Med.39: 184–198 (Aug.) 1965.
32.
ShearL.BonkowskyH. L.GabuzdaG. J.: Renal Tubular Acidosis in Cirrhosis, N. Engl. J. Med.280: 1–7 (Jan.) 1969.
33.
GregoryP. B.BroekelschenP. H.HillM. D.: Complications of Diuresis in the Alcoholic Patient with Ascites: A Controlled Trial, Gastroenterology73: 534–538 (Sept.) 1977.
34.
ConnH. O.: Diuresis of Ascites: Fraught with or Free from Hazard. Gastroenterology73: 619–621 (Sept.) 1977.
35.
ShearL.ChingS.GabuzdaG. J.: Compartmentalization of Ascites and Edema in Patients with Hepatic Cirrhosis, N. Engl. J. Med.282: 1391–1396 (June) 1970.
36.
ShearL.SwartzC.ChinabergerJ. A.: Kinetics of Peritoneal Fluid Absorption in Adult Man, N. Engl. J. Med.272: 123–127 (Jan.) 1965.
37.
SummerskillW. H. J.: Diseases of the Liver, 3rd Ed.SchiffL. (Ed.). J. B. Lippincott, Philadelphia, Pa. pp. 355–377. 1969.
38.
PodolskyS.ZimmermanH. J.BurroughsB. A.: Potassium Depletion in Hepatic Cirrhosis, TV. Engl. J. Med.288: 644–648 (Mar.) 1973.
39.
KnochelJ. P.: The Pathophysiology and Clinical Characteristics of Severe Hypophosphatemia, Arch. Int. Med.137: 203–220 (Feb.) 1977.
40.
DavidsonC. S.GabuzdaG. J.: Diseases of the Liver, 3rd Ed.SchiffL. (Ed.). J. B. Lippincott, Philadelphia, Pa. pp. 378–409, 1969.
41.
ConnH. O.: Current Diagnosis and Treatment of Hepatic Coma. Hosp. Prac.8: 65–72 (Feb.) 1973.
42.
ConnH. O.: A Rational Program for the Management of Hepatic Coma, Gastroenterology56: 715–723 (Dec.) 1969.
RankinJ. R.WilkinsonP.SantamariaJ. N.: Factors Influencing the Prognosis of the Alcoholic Patient with Cirrhosis, Australasian Ann. Med.19: 232–239 (Aug.) 1970.
48.
PowellW. J.KlatskinG.: Duration of Survival in Patients with Laennec's Cirrhosis, Am. J. Med.44: 406–420 (Mar.) 1968.
49.
SummerskillW. H. J.: Hepatic Failure and the Kidney, Gastroenterology51: 94–107 (July) 1968.
50.
ScharschmidtB. F.: Approaches to the Management of Fulminant Hepatic Failure, Med. Clin. N. Am.59: 927–935 (July) 1975.
51.
JonesS. R.: The Absolute Granulocyte Count in Ascites Fluid, Western J. Med.126: 344–346 (May) 1977.